Genomic Profiling
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What Genomic Profiling Means
Genomic profiling, also called genomic characterization or biomarker testing, is a laboratory method that looks closely at the genes in cancer cells. It uses samples of tumor tissue, blood, or other body fluids to find changes or mutations in the DNA of the cancer. These changes can help doctors understand how the cancer started, how it might behave, and which treatments might work best. This testing is done on both solid tumors (like breast or lung cancer) and blood cancers (like leukemia).
Why Genomic Profiling Matters in Cancer Care
Each person’s cancer is unique, with its own pattern of genetic changes. Genomic profiling helps identify these changes, which can influence how the cancer grows and responds to treatment. Some treatments, such as targeted therapies or immunotherapies, are designed to work only if certain genetic changes are present. By knowing the genetic makeup of the cancer, doctors can choose treatments that are more likely to be effective and avoid those that may not help. This approach is part of precision medicine, which aims to tailor cancer care to the individual’s specific disease.
What Patients Might See or Hear About Genomic Profiling
If your doctor suggests genomic profiling, they may explain that this test looks for specific changes in your cancer’s genes. You might hear other names for the test, such as tumor testing, tumor genetic testing, molecular testing, or somatic testing. The results could influence your treatment plan, including the possibility of using drugs approved for other cancer types if your cancer shares the same genetic changes. Sometimes, genomic profiling results are used to find clinical trials that match your cancer’s genetic profile.
Where Genomic Profiling May Appear
You may see the term in your medical records, test reports, treatment plans, or when discussing clinical trials. It is often mentioned when cancer has spread or returned after treatment (advanced cancer). The test results might be part of a companion diagnostic, meaning the test is paired with a specific treatment designed to target the genetic change found.
What Genomic Profiling Does Not Automatically Mean
It is important to know that genomic profiling is not the same as inherited genetic testing. It does not tell you if you were born with a higher risk of cancer. Instead, it looks at changes that happened in the cancer cells themselves. Also, having a genetic change in your cancer does not guarantee that a particular treatment will work, but it helps guide treatment decisions.
How Doctors Use Genomic Profiling
Doctors use genomic profiling to help diagnose the cancer more precisely, plan treatment, and sometimes monitor how well treatment is working. It can also help identify patients who might benefit from newer treatments or clinical trials. For example, if a cancer has a change in a gene like EGFR, doctors may use a targeted drug that works specifically on that change. Genomic profiling is especially common for cancers that have spread or come back after initial treatment.
Common Sources of Confusion
Because genomic profiling has many names—such as biomarker testing, tumor testing, or molecular testing—it can be confusing. Also, it is different from genetic testing that looks for inherited cancer risks. Understanding these differences can help you ask the right questions and better understand your care.
Next Steps and Questions to Ask
If genomic profiling is recommended, you might ask your care team what specific changes the test looks for, how the results could affect your treatment, and whether there are clinical trials that match your cancer’s genetic profile. Remember, this information helps guide decisions but does not guarantee a particular outcome.
Important Safety and Context
This information is educational and does not decide what is safe or appropriate for any individual patient. If genomic profiling appears in your medical records or treatment plan, the best next step is to ask your doctor or care team what it means for your specific situation.
Sources
Public source information used for this glossary entry includes: